Evidence map›Paper›PMID 42726805›Full record

ArticlePloS one2026

Dual-domain self-supervised feature alignment via spectral-spatial representation learning for deepfake anomaly detection.

Yi He

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Yi HeSchool of Computer and Data Science, Henan University of Urban Construction, Pingdingshan, Henan, China.ORCID https://orcid.org/0009-0004-9387-4934

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deepfake anomaly detection has become increasingly critical in visual security applications. However, many existing methods rely heavily on large-scale supervised forgery annotations and often struggle to capture subtle manipulation traces distributed across both spatial and frequency domains. To address these limitations, we propose a Self-Supervised Dual-Domain Alignment (SDDA) framework that jointly learns spatial and spectral representations without requiring labeled forged samples. Specifically, SDDA employs two parameter-sharing encoders to extract complementary features from RGB images and their frequency-domain counterparts, while a cross-domain alignment module enforces consistency between spatial textures and spectral signatures. To provide explicit and reproducible self-supervised supervision, four complementary descriptors are further derived from FAN feature maps: Local Structural Deviation (LSD) for local gradient inconsistency, Global Pattern Discrepancy (GPD) for holistic channel-correlation differences, Local Residual Difference (LRD) for residual-level inconsistency, and Total Consistency Deviation (TCD) for multi-layer feature deviation. These descriptors are predicted from the fused spatial-frequency embedding, encouraging the model to learn manipulation-sensitive representations in the absence of fake samples. In addition, a dual-domain contrastive objective enhances the discrimination of subtle forgery-related anomalies while improving robustness against real-world degradations such as compression and illumination variations. Experimental results demonstrate that SDDA consistently outperforms state-of-the-art baselines, particularly under challenging unseen-manipulation scenarios. Overall, the proposed framework provides an interpretable and label-efficient solution for dual-domain deepfake anomaly detection.

Indexed as

Image Processing, Computer-AssistedAlgorithmsRepresentation Machine Learning

Identifiers

PMID42726805
PMCPMC13568503

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.